Amir Avan
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 2%
- Colorectal Cancer Treatments and Studies
Papers in
-
- MicroRNA in disease regulation 31
- Oncology 62
- Pancreatic and Hepatic Oncology Research 18
- Colorectal Cancer Treatments and Studies 12
- Co-authors
- Seyed Mahdi Hassanian (184 shared papers)Gordon A. Ferns (221 shared papers)Majid Ghayour‐Mobarhan (116 shared papers)Majid Khazaei (165 shared papers)Soodabeh Shahidsales (53 shared papers)Afsane Bahrami (44 shared papers)Mina Maftouh (24 shared papers)Mikhail Ryzhikov (47 shared papers)
- Journals
- Journal of Cellular Physiology (59 papers)Journal of Cellular Biochemistry (33 papers)Current Pharmaceutical Design (32 papers)Gene (9 papers)Current Cancer Drug Targets (8 papers)
- Partner nations
- IranUnited KingdomUnited States
In The Last Decade
Amir Avan
357 papers receiving 9.9k citations
Peers
Comparison fields: 5 of 132
- Cancer Research 1.6k
- Oncology 1.4k
- Biological Psychiatry 84
- Molecular Medicine 326
- Drug Discovery 13
Countries citing papers authored by Amir Avan
This map shows the geographic impact of Amir Avan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amir Avan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amir Avan more than expected).
Fields of papers citing papers by Amir Avan
This network shows the impact of papers produced by Amir Avan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amir Avan. The network helps show where Amir Avan may publish in the future.
Co-authors
The 25 scholars most cited alongside Amir Avan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 363 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 252 | |
| 2 | 2019 | 238 | |
| 3 | 2017 | 203 | |
| 4 | 2016 | 192 | |
| 5 | 2019 | 171 | |
| 6 | 2015 | 159 | |
| 7 | 2018 | 147 | |
| 8 | 2017 | 141 | |
| 9 | 2017 | 138 | |
| 10 | 2017 | 133 | |
| 11 | 2018 | 131 | |
| 12 | 2018 | 118 | |
| 13 | 2018 | 118 | |
| 14 | 2015 | 117 | |
| 15 | 2017 | 116 | |
| 16 | 2017 | 111 | |
| 17 | 2016 | 109 | |
| 18 | 2017 | 108 | |
| 19 | 2017 | 105 | |
| 20 | 2017 | 99 |
About Amir Avan
Amir Avan is a scholar working on Cancer Research, Oncology, Molecular Biology, Pathology and Forensic Medicine and Genetics, having authored 363 papers that have together received 10.1k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (31 papers), Pancreatic and Hepatic Oncology Research (18 papers), Genetic Associations and Epidemiology (18 papers), Nanoparticle-Based Drug Delivery (12 papers), Vitamin D Research Studies (12 papers), Colorectal Cancer Treatments and Studies (12 papers), Curcumin's Biomedical Applications (12 papers) and Wnt/β-catenin signaling in development and cancer (11 papers). The work is most often cited by research in Cancer Research (1.6k citations), Oncology (1.4k citations), Biological Psychiatry (84 citations), Molecular Medicine (326 citations) and Drug Discovery (13 citations). Amir Avan has collaborated with scholars based in Iran, United Kingdom and United States. Frequent co-authors include Seyed Mahdi Hassanian, Gordon A. Ferns, Majid Ghayour‐Mobarhan, Majid Khazaei, Soodabeh Shahidsales, Afsane Bahrami, Mina Maftouh, Mikhail Ryzhikov, Farzad Rahmani and Atena Soleimani. Their work appears in journals such as Journal of Cellular Physiology, Journal of Cellular Biochemistry, Current Pharmaceutical Design, Gene and Current Cancer Drug Targets.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.